Abstract:
Objective To investigate the genetic polymorphisms of folate metabolism related genes in reproductive age women in Jiangmen and to provide data support for the guidance of reasonable folate supplementation for women of childbearing age in this area.
Methods A total of 636 reproductive age women in our hospital were enrolled as the study subjects from October 2, 2016 to September 19, 2017. The oral mucosal epithelial cells of the study subjects were collected, and 5, 10-methylene was measured by the Taqman-MGB method. The genotypes of the tetrahydrofolate reductase (MTHFR) C667 T, A1298 C locus, and the methionine synthase reductase (MTRR) A66 G locus were analyzed.
Results Among the MTHFR C667 T sites detected in all samples, wild-type (CC), heterozygous mutant (CT) and homozygous mutant (TT) accounted for 60.69%, 32.23% and 7.08%. The gene frequency of the mutant gene T was 23.19%. The wild type (AA), heterozygous mutant (AC) and homozygous mutant (CC) in the MTHFR A1298 C locus were 60.53%, 32.55% and 6.92, respectively. The gene frequency of the mutant gene C was 23.19%. The wild type (AA), heterozygous mutant (AG) and homozygous mutant (GG) in the MTRR A66 G locus were 54.09%, 45.28% and 10.06%, respectively. The gene frequency of the mutant gene G was 32.70%. The genotype distribution of MTHFR C667 T locus was significantly different from that of Chinese population (
P=0.000), but there was no significant difference in the genotype distribution of MTHFR A1298 C and MTRR A66 G loci between the study subjects and the Chinese populations (
P=0.496,
P=0.296). There was a statistically significant difference in the frequency distribution of MTHFR C667 T allele between reproductive age women in Jiangmen area and Chinese population was (
P=0.000). There was 59.43% of reproductive age women with folic acid metabolism disorder.
Conclusion More than 50% of reproductive age women in Jiangmen area carry high-risk genes. The clinicians should provide folic acid supplementation guidance during pregnancy based on genetic polymorphism of folic acid metabolism in order to avoid adverse pregnancy outcomes caused by folate deficiency due to folate metabolism and newborn defect.